New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
复制标题

DOI:
10.1002/jha2.70
复制
发表时间:
2020-11
期刊:
EJHaem
影响因子:
--
通讯作者:
Engelhardt BG
Engelhardt BG
中科院分区:
其他
文献类型:
--
作者:
Mangan BL;Patel D;Chen H;Gatwood KS;Byrne MT;Sengsayadeth S;Goodman S;Dholaria B;Kassim AA;Jagasia M;Chinratanalab W;Culos KA;Engelhardt BG

文献摘要

参考文献

被引文献

相似文献

半相合造血细胞移植(Haplo-HCT)与移植后环磷酰胺(PTCY)联合应用于无传统供者的血液病患者。单核细胞移植后新发糖尿病(PTDM)的影响尚不清楚。我们研究了PTCY单次HCT后PTDM的发生率和预后。对接受单核细胞移植的非糖尿病患者()诊断为PTDM(定义为血糖≥200 mg/dL)进行分析。到第100天,14名患者(22%)发展为PTDM(中位数为18天)。在11例(79%)患者中,高血糖(血糖≥200m g/dL)先于皮质类固醇激素。PTDM患者死亡/复发增加(P=0.029)。PTDM经常发生,先于皮质类固醇激素,并导致单纯性HCT后预后较差。PTDM的预防/治疗可提高HCT的存活率。
Haploidentical hematopoietic cell transplantation (haplo‐HCT) with posttransplant cyclophosphamide (PTCY) is utilized for patients with hematological disorders but without conventional donors. The effects of new‐onset posttransplant diabetes mellitus (PTDM) following haplo‐HCT are unknown. We examined PTDM incidence and outcomes after haplo‐HCT with PTCY. Patients without diabetes receiving haplo‐HCT (n = 64) were analyzed for PTDM diagnosis (defined as blood glucose ≥ 200 mg/dL). By day 100, 14 (22%) patients developed PTDM (median, 18 days). Hyperglycemia (blood glucose ≥ 200 mg/dL) preceded corticosteroids in 11 (79%) individuals. PTDM patients had increased death/relapse (P = .029). PTDM occurs frequently, precedes corticosteroids, and leads to inferior outcomes following haplo‐HCT. PTDM prophylaxis/treatment may improve HCT survival.
DOI: 10.1016/j.bbmt.2008.12.488
发表时间: 2009-03-01
影响因子: 4.3
作者:
Hammer, Marilyn J.;Casper, Corey;Hirsch, Irl B.
通讯作者: Hirsch, Irl B.
DOI: 10.1182/blood-2014-01-552984
发表时间: 2014-06-05
期刊: BLOOD
影响因子: 20.3
作者:
Armand, Philippe;Kim, Haesook T.;Saber, Wael
通讯作者: Saber, Wael
DOI: 10.1016/j.bbmt.2019.02.001
发表时间: 2019-06-01
影响因子: 4.3
作者:
Engelhardt, Brian G.;Savani, Ujjawal;Abumrad, Naji N.
通讯作者: Abumrad, Naji N.
DOI: 10.1016/j.bbmt.2009.05.010
发表时间: 2009-09-01
影响因子: 4.3
作者:
Majhail, Navneet S.;Challa, Tejo R.;Burns, Linda J.
通讯作者: Burns, Linda J.
DOI: 10.1182/blood-2006-05-022335
发表时间: 2007-02-15
期刊: BLOOD
影响因子: 20.3
作者:
Baker, K. Scott;Ness, Kirsten K.;Bhatia, Smita
通讯作者: Bhatia, Smita